Abbvie (ABBV) Financials
Abbvie (ABBV) Historical Financial Statements and Key Metrics for 2011 - 2020
Full Abbvie financials for 2011 - 2020 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Abbvie Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2020-Dec-31 | 13,858 | 9,174 (66.2 %) | 4,053 (-10.9 %) | 36 (0.3 %) | -572 | 0.01 |
| 2020-Sep-30 | 12,902 | 7,852 (60.9 %) | 3,255 (19.4 %) | 2,308 (17.9 %) | 5,442 | 1.29 |
| 2020-Jun-30 | 10,425 | 6,714 (64.4 %) | 752 (-6.6 %) | -738 (-7.1 %) | 1,523 | -0.46 |
| 2020-Mar-31 | 8,619 | 6,677 (77.5 %) | 3,603 (41.8 %) | 3,010 (34.9 %) | 4,220 | 1.87 |
| 2019-Dec-31 | 8,704 | 6,650 (76.4 %) | 3,956 (45.5 %) | 2,801 (32.2 %) | 4,142 | 1.88 |
| 2019-Sep-30 | 8,479 | 6,517 (76.9 %) | 2,617 (30.9 %) | 1,884 (22.2 %) | 2,984 | 1.27 |
| 2019-Jun-30 | 8,255 | 6,399 (77.5 %) | 3,400 (41.2 %) | 741 (9.0 %) | 1,667 | 0.50 |
Full historical income statements for 2011 - 2020 is included in the
US Historical Financials dataset.
Abbvie Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2020-Dec-31 | 150,565 | 137,489 | 8,502 | 13,076 | 8,479 |
| 2020-Sep-30 | 149,621 | 134,332 | 87,059 | 15,270 | 7,950 |
| 2020-Jun-30 | 149,530 | 134,798 | 87,432 | 14,708 | 6,040 |
| 2020-Mar-31 | 91,199 | 98,614 | 67,046 | -7,415 | 41,142 |
| 2019-Dec-31 | 89,115 | 97,287 | 66,728 | -8,172 | 39,924 |
| 2019-Sep-30 | 59,441 | 67,667 | 38,402 | -8,226 | 10,648 |
| 2019-Jun-30 | 57,142 | 65,708 | 37,260 | -8,566 | 5,416 |
Full historical balance sheet data for 2011 - 2020 is included in the
US Historical Financials dataset.
Abbvie Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2020-Dec-31 | -12,734 | -37,557 | -11,501 | -13,013 |
| 2020-Sep-30 | 5,830 | 0 | 0 | 5,613 |
| 2020-Jun-30 | 3,089 | 0 | 0 | 2,912 |
| 2020-Mar-31 | 3,815 | -129 | -2,422 | 3,690 |
| 2019-Dec-31 | 3,275 | -615 | 26,602 | 3,112 |
| 2019-Sep-30 | 4,555 | 1,378 | -441 | 4,401 |
| 2019-Jun-30 | 2,477 | -140 | -2,070 | 2,349 |
Full historical cash flow data for 2011 - 2020 is included in the
US Historical Financials dataset.
Abbvie Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2020-Dec-31 | 189,171 | 189,224 | 13.65 | 5,254.74 | 14.47 |
| 2020-Sep-30 | 154,622 | 229,074 | 11.98 | 66.99 | 10.13 |
| 2020-Jun-30 | 159,753 | 235,820 | 15.32 | -216.47 | 10.86 |
| 2020-Mar-31 | 119,221 | 141,369 | 13.83 | 39.61 | -16.08 |
| 2019-Dec-31 | 126,452 | 149,503 | 14.53 | 45.15 | -15.47 |
| 2019-Sep-30 | 104,757 | 127,235 | 12.35 | 55.60 | -12.73 |
| 2019-Jun-30 | 100,089 | 126,842 | 12.12 | 135.07 | -11.68 |
Full historical valuation and operating metrics for 2011 - 2020 are included in the
US Historical Financials dataset.